Clinical Trial Update: Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is recruiting to evaluate the effects of semaglutide on intracranial blood flow and brain-blood barrier permeability in adults with typ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke
• Transient Ischemic Attack
• Type 2 Diabetes Mellitus

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: University of Washington | Conditions: Diabetes Mellitus, Type 2, Stroke (CVA) or Transient Ischemic Attack | Phase 4 | Status: RECRUITING